Evidence map›Paper›PMID 35056007›Full record

ArticlePathogens (Basel, Switzerland)2022

Rapid Detection of Quinolone Resistance Mutations in

Franziska Haumaier, Anna Schneider-Fuchs, Steffen Backert, Michael Vieth, William Sterlacci, Birgitta M Wöhrl

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Association of Resistance-AssociatedAntibiotics (Basel, Switzerland) · 2026
    Article
  3. Treatment of Helicobacter pylori Infection in Korea: An Evidence-Based Analysis of the Upcoming 2025 Guideline.The Korean journal of helicobacter and upper gastrointestinal research · 2026
    Review
  4. Article
  5. Challenges and Prospects for Eradication ofPathogens (Basel, Switzerland) · 2025
    Review
  6. Prevalence and Variability ofAntibiotics (Basel, Switzerland) · 2025
    Article
  7. Overcoming antibiotic-resistantWorld journal of gastroenterology · 2025
    Review
  8. Article
  9. Review
  10. Effect and Safety ofInfection and drug resistance · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Franziska HaumaierLehrstuhl Biochemie IV-Biophysikalische Chemie, Universität Bayreuth, Universitätsstraße 30, 95447 Bayreuth, Germany.
Anna Schneider-FuchsInstitut für Pathologie, Klinikum Bayreuth, Preuschwitzer Straße 101, 95445 Bayreuth, Germany.
Steffen BackertDepartment Biologie, Lehrstuhl Für Mikrobiologie, Friedrich-Alexander Universität Erlangen-Nürnberg, Staudtstraße 5, 91058 Erlangen, Germany.ORCID 0000-0002-8948-8254
Michael ViethInstitut für Pathologie, Klinikum Bayreuth, Preuschwitzer Straße 101, 95445 Bayreuth, Germany.
William SterlacciInstitut für Pathologie, Klinikum Bayreuth, Preuschwitzer Straße 101, 95445 Bayreuth, Germany.
Birgitta M WöhrlLehrstuhl Biochemie IV-Biophysikalische Chemie, Universität Bayreuth, Universitätsstraße 30, 95447 Bayreuth, Germany.ORCID 0000-0002-6024-9487
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEBayreuth Medical Center · DEUniversity of Bayreuth · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The treatment of infections by the gastric pathogen

Indexed as

antibiotic resistanceFRETgyrAHelicobacter pyloriQRDR mutation diagnosisquinolone resistanceRT-PCR

Identifiers

PMID35056007
PMCPMC8781667
OpenAlexW4206825941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.